Harvard's PDGrapher AI tool forecasts gene-drug pairings that restore diseased cells, marking a breakthrough in precision ...

Adults with learning disabilities and newly diagnosed type 2 diabetes (T2D) have better short-term glycemic control.

Men, black communities and the poorly educated are experiencing significant disparities in accessing game-changing digital ...

Artificially generated data can help to train AI models when real data are scant, but more focus is needed on validating the ...

This article explores how immune biomarkers can predict disease risk, guide treatment choices and overcome challenges to ...

In a move that could reshape drug discovery, researchers at Harvard Medical School have designed an artificial intelligence ...